Success Metrics

Completion Rate

0%(0/2)

Active Trials

1(25%)

Terminated

2(50%)

Phase Distribution

Ph not_applicable

25%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Terminated(3)

Detailed Status

Terminated2

Withdrawn1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (50.0%)

N/A1 (50.0%)

Trials by Status

withdrawn125%

active_not_recruiting125%

terminated250%

Recent Activity

1 active trials

Showing 4 of 4

active_not_recruitingphase_1

Clinical Trials (4)

Showing 4 of 4 trials

NCT01426529Phase 1

Caveolin-1 and Vascular Dysfunction

Active Not Recruiting

NCT01511042

Vascular Dysfunction in Diabetes: Genes and Hormones

Terminated

NCT01456208

Genetic Mechanisms in Human Hypertension

Terminated

NCT01702688Not Applicable

Evaluation of Lysine-Specific Demethylase 1

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4